Literature DB >> 6722763

Chromosome studies in polycythemia vera patients.

R Berger, A Bernheim, M Le Coniat, D Vecchione, G Flandrin, C Dresch, Y Najean.   

Abstract

One hundred thirty-five polycythemia vera (PV) patients (30 untreated by chemotherapy and 105 treated) were studied cytogenetically . The incidence of clonal chromosomal abnormalities was 20.7% (28 patients in nonleukemic phase). The incidence of 20q - was 3.7% (5 patients). The presence of cytogenetically abnormal clones did not allow prediction of the evolution of the disease. In a few cases, abnormal clones disappeared at the time of later studies. Although nonrandom, the majority of clonal chromosomal abnormalities are believed to be secondary events in PV patients.

Entities:  

Mesh:

Year:  1984        PMID: 6722763     DOI: 10.1016/0165-4608(84)90033-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Labeling of the centromeric region on human chromosome 8 by in situ hybridization.

Authors:  H U Weier; H D Kleine; J W Gray
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 2.  The map of chromosome 20.

Authors:  N E Simpson
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

3.  Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group.

Authors:  Kazuo Dan; Takashi Yamada; Yukihiko Kimura; Noriko Usui; Shinichirou Okamoto; Takashi Sugihara; Kazue Takai; Michihiko Masuda; Mayumi Mori
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

4.  Polycythemia vera. A clinical study of 141 patients.

Authors:  B Anger; U Haug; R Seidler; H Heimpel
Journal:  Blut       Date:  1989-12

5.  A novel chromosomal abnormality, t(6;10)(q27;q22), found in a polycythemic potential donor for allogeneic hematopoietic stem cell transplantation.

Authors:  Hideki Mitsui; Norimitsu Saito; Atsushi Satake; Tsuyoshi Nakazawa; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.